Condensed Consolidated Statements of Operations (Parenthetical) - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Jun. 30, 2025 |
Jun. 30, 2024 |
Jun. 30, 2025 |
Jun. 30, 2024 |
|
| Total equity-based compensation expense | $ 37,548 | $ 24,858 | $ 61,260 | $ 49,083 |
| Cost of revenue | ||||
| Total equity-based compensation expense | 4,619 | 3,273 | 8,083 | 6,419 |
| Research and development | ||||
| Total equity-based compensation expense | 8,792 | 9,182 | 17,490 | 18,093 |
| Sales and marketing | ||||
| Total equity-based compensation expense | 10,182 | 2,692 | 14,191 | 6,513 |
| General and administrative | ||||
| Total equity-based compensation expense | $ 13,955 | $ 9,711 | $ 21,496 | $ 18,058 |